Home › Coronary Artery Disease › New Hampshire
Coronary Artery Disease clinical trials in New Hampshire
3 studies for Coronary Artery Disease are looking for participants at sites in New Hampshire.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Seacoast Kidney and Hypertension Specialists, Portsmouth
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Dartmouth Hitchcock Medical Center, Lebanon
Recruiting
All ages · All sexes · Updated Jul 24, 2025 · NCT04634240From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.